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A B S T R A C T
The high death rate associated with cancer has fuelled the search for complementary cancer treatment methods
in recent times. Among the leading alternative methods is natural products which have attracted much attention
due to their high body tolerance. In this study, the caps of Flammulina velutipes (commonly called Enoki), an
edible mushroom, were extracted with diﬀerent solvents and characterized for in vitro antioxidant and antic-
ancer activities. The anticancer activity of the extract was studied against breast cancer cells (MCF-7 and MDA-
MD-231) and normal or Vero breast cells (MCF-10a). The radical scavenging, metal reducing power, and an-
ticancer properties of the extracts were investigated via in vitro chemical and cell-based methods. Furthermore, a
phytochemical proﬁling process was performed on the extract fraction with the highest level of biological ac-
tivities using Liquid chromatography-mass spectrometry coupled with quadrupole time of ﬂight (LC-MS-QTof).
The results showed acetone fraction of Enoki caps to exhibit more radical scavenging activity against 2,2-di-
phenyl-1-picrylhydrazyl (DPPH) free radicals (IC50= 0.840mg/mL) and hydrogen peroxide (H2O2) radicals
(IC50= 0.890mg/mL) compared to the ethyl acetate fraction (IC50= 0.97 mg/mL against DPPH and 1.180mg/
mL against H2O2). Additionally, acetone fraction showed a better metal reducing property in a concentration-
dependent manner. The in vitro cytotoxicity study showed a preferential level of toxicity of the acetone extract to
the studied cancer cell lines compared to the Vero cells. This extract showed more cytotoxicity against MCF-7
(IC50 value ranged from 17.7 µg/mL to 38.36 µg/mL) and MDA-MB-231 (IC50 value ranged from 114.5 µg/mL to
184.2 µg/mL) compared to MCF-10a (> 250 µg/mL). These ﬁndings present F. velutipes caps as a potential
natural source of antioxidant and anticancer agents.
1. Introduction
Cancer is a globally recognized deadly disease that is associated
with a high mortality rate. It results from an uncontrolled growth of
cells or a defect in the genes that control normal cell division and
growth (National Cancer Institute, 2015). According to the US breast
cancer statistics report of 2018, breast cancer is a leading cause of death
globally. About 266,120 new cases of invasive breast cancer have been
forecasted to occur in the USA alone by 2018, while about 63,960 new
non-invasive cases will be diagnosed. As per the number of deaths ex-
pected from breast cancer-related cases, approximately 40,920 deaths
have been predicted in the USA in 2018 alone. The January 2018 report
showed more than 3.1 million US women having a history of breast
cancer (US Breast Cancer Statistics, 2018). These are challenging
ﬁndings that require expedient action towards diversifying the sources
of anticancer agents. Although chemotherapy and irradiation are the
commonest forms of treatment for cancer, early detection and preven-
tion remain the best approach (National Cancer Institute, 2015).
Mushrooms have served as a major source of dietary nutrients and
wholesome body beneﬁts due to their low fat and caloric contents, as
well as their high essential amino acids, minerals, and vitamins content
(Ramesh and Manohar, 2010). However, more eﬀort has recently been
dedicated to mushrooms as a source of phytochemicals with medicinal
eﬀects (Madhanraj et al., 2017). Mushrooms have been found to con-
tain some phytochemicals with both anti-hypertensive, cholesterol-
lowering, and anti-cancer activities (Bobek and Galbavy, 1999). The
health beneﬁts associated with mushroom consumption are attributable
to their richness in phenolic compounds (Esmaeili et al., 2011). In
China, Japan, and Korea, several mushroom extracts are widely used as
potential adjuvants to chemotherapy and radiation treatments in cancer
management (Sullivan et al., 2006; Borchers et al., 2008). However,
most reports on the major medicinal properties of mushrooms have
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been on their antioxidant, immune modulation, anticancer, antiviral,
and anticholesterolemic eﬀects (Bobek and Galbavy, 2008; Nowacka
et al., 2015). Diﬀerent parts of mushrooms contain diﬀerent phyto-
chemicals that have diﬀerent biological/pharmacological eﬀects.
Mushroom cap extracts have been reported to be more biologically
active due to the higher concentration of phytochemicals in the caps
compared to the stem (Ukaegbu and Shah, 2017; Akyuz and Kirbag,
2009; Breene, 1990; Sun et al., 2014). Phytochemicals can be extracted
from mushrooms only when suitable solvents with a suitable level of
polarity are used during the extraction process (Alnoumani et al.,
2017). It is often diﬃcult to identify a single solvent that can eﬃciently
extract all the phytochemicals in any biological material (Akowuah
et al., 2009). Because of this challenge, researchers have adopted the
method of using solvents with varying levels of polarity when targeting
diﬀerent components of biological materials. Thus, this study aims to
evaluate the eﬀect of solvent (acetone and ethyl acetate) polarity on the
biological activities of extracts from the dried caps of Flammulina ve-
lutipes (common name – Enoki) This mushroom was selected for this
study due to the lack of supportive evidence on the anticancer activity
of its extracts against human breast cancer despite its abundance in the
study area.
2. Material and methods
2.1. Mushroom sample
The mushroom (F. velutipes, henceforth referred to as Enoki), was
ﬁrst identiﬁed based on literature evidence and supplied by a local
biological materials supplier in Kuantan, Pahang, Malaysia.
2.2. Chemicals used
Folin reagent, 2,2-diphenyl-1-picrylhydrazyl (DPPH), anhydrous
sodium carbonate, monobasic and dibasic potassium phosphate, 50%
hydrogen peroxide solution, gallic acid, potassium ferricyanide, alu-
minum chloride, trichloroacetic acid (TCA), quercetin, ascorbic acid,
and ferric chloride were bought from Merck- Louis, MO, USA. MCF-7,
MDA-MB-231, and MCF-10a were bought from ATCC (USA). The cell
culture media (Dulbecco’s Modiﬁed Eagles Medium) and the supple-
ments (Fetal Bovine Serum and Penicillin/Streptomycin solution) were
purchased from Merck- Darmstadt, Germany. Phosphate Buﬀered
Saline, and 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium
Bromide (MTT) cytotoxicity assay kit were bought from Solarbio,
China.
2.3. Preparation and extraction
The mushrooms were ﬁrst separated into caps and stems; the caps
were dried to a constant weight in an incubator at 70 °C. A drying
temperature of 70 °C was preferred to ensure a complete drying of the
extracts within a short time since the water content of the mushroom
was about 95% total weight. This drying temperature of 70 °C has been
previously reported to have little or no signiﬁcant eﬀect on the phy-
tochemical content of biological materials (Hazrulrizawati et al., 2016).
The dried mushroom caps were pulverized and preserved in a dark
plastic bag prior to use. For the extraction, 180 g of the pulverized
mushroom caps was weighed and added into a 500-mL ﬂat bottom
conical ﬂask, followed by the addition of 500mL of acetone or ethyl
acetate. The ﬂask was covered with aluminum foils, mounted on a ro-
tary shaker at 250 rpm, and shaked for 24 h at ambient temperature
(25 ± 2.4 °C). After the extraction process, the suspension was ﬁltered
through several changes of Whatman no. 1 ﬁlter paper and later con-
centrated in a rotary evaporator (EYELA rotary system). The con-
centrated extract was further allowed to dry under a hood chamber. The
dried extract was stored in sterile universal bottles and preserved at
−20 °C. The extraction yields of the acetone and ethyl acetate processes
were 17.4% and 12.5%, respectively
2.4. Total phenolic content (TPC) evaluation
The TPC of the extracts was evaluated using the guideline provided
by Slinkard and Slingleton (1997) and later modiﬁed by Seonwook
et al. (2017). In this process, the extract was ﬁrst solubilized in distilled
water at 1mg/mL concentration. Further, 1 mL of the extract solution
was added to a conical ﬂask (100mL volume), followed by the addition
of 45mL of distilled water. Then, Folin-phenol reagent (1 mL) was
added to the solution and mixed. The ﬂask was incubated at ambient
temperature for 3min before adding 3mL of 2% Na2CO3 solution. The
ﬂask was further allowed for 2 h at ambient temperature with occa-
sional shaking. After 2 h, the absorbance of the solution was read at
760 nm. Gallic acid was used as the standard phenol source (for de-
veloping the standard curve). All the experiments were carried out in
triplicate while the ﬁndings were presented as the mean ± SD of tri-
plicate measurements. The TPC of the extract was determined as mi-
crograms of gallic acid equivalent (µgGAE/mg) from the prepared
standard curve (R2=0.99).
2.5. Total ﬂavonoids content (TFC) evaluation
The TFC of the extracts was evaluated using a standard guideline
provided by Meda et al. (2005) and Muhammad et al. (2017). Brieﬂy,
equal volumes of 2% AlCl3 (prepared in absolute methanol) and the
extracts (1 mg/mL in absolute methanol) were incubated in a glass tube
for 10min at ambient temperature. After 10min, the absorbance of the
mixture at 415 nm was determined in a spectrophotometer. Quercetin
was used at diﬀerent concentrations to prepare the standard curve
(R2= 0.98). The TFC of the extract was determined from the quercetin
curve in micrograms of quercetin equivalent (QE)/mg and presented as
the mean ± SD of triplicate measurements.
2.6. Antioxidant activity
In vitro-based chemical methods were used to evaluate the anti-
oxidant activities of the extracts. These methods are based on the ability
of the extracts at diﬀerent concentrations to scavenge free radicals and
to reduce metals.
2.6.1. DPPH free radical scavenging
Diﬀerent concentrations of the extracts were studied for DPPH ra-
dicals scavenging using a standard method (Dorman et al., 2004;
Hajdari et al., 2018). First, a methanol solution of DPPH (126 µM) was
prepared. Furthermore, diﬀerent concentrations of the extracts
(0.2–1.0mg/mL) were prepared in distilled water. For the assay, 1 mL
of the extract solutions (diﬀerent concentrations) was incubated with
2mL of DPPH solution in capped glass tubes in a dark cupboard for
30min at ambient temperature. A control set-up was prepared in a si-
milar way but without the extract. After the incubation time, the fading
of the purple color of the DPPH solution which indicates radical sta-
bilization was monitored in a spectrophotometer at 517 nm. A standard
protocol was set up using ascorbic acid at the equivalent concentra-
tions. The DPPH radical scavenging activity of the extract was de-
termined (using Eq. (1) and both as IC50 values and as percentages with
respect to the initial DPPH concentration.
= ⎡
⎣⎢
− ⎤
⎦⎥
∗DPPH scavenging effect A A
A
(%) 1000 1
0 (1)
where
A0= control absorbance
A1= test/standard absorbance.
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2.6.2. Hydrogen peroxide (H2O2) radical scavenging
Likewise, the extracts were evaluated for H2O2 radicals scavenging
using a standard method (Odeja et al., 2017). Brieﬂy, a 40mM H2O2
solution was ﬁrst prepared; then, 50-mM phosphate buﬀer solution (pH
7.4) was prepared as well. The initial concentration of radicals in the
prepared 40mM H2O2 solution was determined against a phosphate
buﬀer blank at 230 nm and the absorbance was recorded as A0. For the
assay, 3.4 mL of the H2O2 solution was incubated with diﬀerent con-
centrations (0.2–1.0mg/mL) of the extracts (0.6 mL) for 10min at
ambient temperature. After the incubation, the absorbance of the so-
lutions was read spectrophotometrically at 230 nm and recorded as A1.
The activity of the extracts was determined by estimating the percen-
tage of the initial free H2O2 radicals scavenged after 10min of in-
cubation with diﬀerent concentrations of the extracts using Eq. (2).
Ascorbic acid was used as a standard during the investigation. The
activity of the extracts was expressed both as percentages (with respect
to the initial concentration of H2O2) and as IC50 values, where higher
percentages and lower IC50 values indicate stronger antioxidant activ-
ities.
= ⎡
⎣⎢
− ⎤
⎦⎥
∗Hydrogen peroxide scavenged A A
A
(%) 1000 1
0 (2)
2.6.3. Ferric reducing antioxidant power (FRAP)
The metal reducing capability of the extracts was evaluated using a
procedure presented by Maruthamuthu and Ruckmani (2016). The
extracts were ﬁrst reconstituted in distilled water at diﬀerent con-
centrations (0.2–1.0mg/mL). Then, 1mL of the extracts (diﬀerent
concentrations) was added into glass tubes containing 2.5mL of 0.2 M
sodium phosphate (pH 6.6) buﬀer. Furthermore, 2.5mL of 1% po-
tassium ferricyanide solution was added into the tubes. The tubes were
capped, shaken, and allowed to incubate for 20min at 50 °C. After the
incubation, 10% TCA solution (2.5 mL) was added to each tube. At this
stage, the tubes were vigorously shaken before being centrifuged at
3000 g for 10min. After centrifugation, 2.5 mL of the supernatants were
carefully transferred to a new set of tubes, followed by the addition of
2.5 mL of deionized water. Finally, 0.1% FeCl3 solution (0.5 mL) was
added to the tubes to initiate a redox reaction between the antioxidants
in the extracts and the introduced unstable ferric ions. This reaction
manifests in the formation of a colored complex with TCA. The absor-
bance of this complex, which reﬂects the strength of the antioxidant
present in the sample, was read at 700 nm in a spectrophotometer.
During this process, a standard protocol was equally set up with as-
corbic acid. The observed FRAP of the extracts was reported as the
mean ± SD of triplicate absorbance readings.
2.7. Cytotoxicity assay
2.7.1. MTT assay
The cytotoxicity of the acetone extract (selected fraction because of
its higher antioxidant activity) was determined in vitro when the con-
ﬂuence the of the cultured cells was up to 80% (Mftah et al., 2015). A
50-mg stock extract solution was ﬁrst made and further diluted to the
required working concentrations of 3.91–250 µg/mL. This concentra-
tion range was used to ensure that the cytotoxicity of the extract could
be monitored at high and low concentrations. The cells were seeded
into 96-well transparent microtiter plates at the concentration of
5× 103 cells/mL (counted using a hemocytometer method) and in-
cubated for 24 h at 37 °C with 5% CO2 concentration. After 24 h, the
media in the wells were carefully replaced with fresh media supple-
mented with diﬀerent extract concentrations to ﬁnal concentrations of
250, 125, 62.5, 31.25, 15.63, 7.81, and 3.91 µg/mL. The media in the
positive control wells were replaced with fresh media supplemented
with doxorubicin at the same concentration as the extracts, while the
media in the negative control cells were replaced with just fresh media.
All the treatment groups were prepared in three 96-well transparent
microtiter plates. One set of the plates was incubated for 24 h, while the
second and third sets were incubated for 48 and 72 h, respectively. At
the end of each incubation period, MTT solution (10 µL) was added into
the wells and allowed to incubate for 4 h at 37 °C. After 4 h, 10% DMSO
(100 µL) was added to the wells to facilitate the solubilization of the
formed formazan crystals by the mitochondrial dehydrogenase of the
viable cells. The absorbance of the formed purple color which is
equivalent to the viable cells population in each well was determined at
570 nm in a plate reader. The cytotoxicity of the extracts was de-
termined and expressed as the percentage of viable cells relative to the
untreated control using Eq. (3). The concentration of extract needed to
reduce the population of the viable cells by 50% (IC50 values) was
determined from a prepared concentration-cell death plot of the ex-
tract.
= ⎡
⎣⎢
⎤
⎦⎥
∗Cytotoxicity Absorbance of Treated cells
Absorbance of Control cells
(%) 100%
(3)
2.7.2. Cell morphology
Having determined the IC50 value of the extract, a fresh population
of cells was cultured in a 6-well transparent culture plate at the con-
centration of 5×103 cells/mL. The cells were incubated overnight to
attach to the plates at 37 °C. After attachment, the media in the wells
were replaced with fresh media containing the IC50 concentration of the
extract. The ﬂask was further incubated for 72 h with a 24-hourly
morphological observation of the cells for signs of stress or induction of
apoptosis. The morphology of the cells after 48 and 72 h was directly
captured using an OLYMPUS camera mounted on an inverted Olympus
light microscope (Hazrulrizawati et al., 2018).
2.8. LC-MS-QTof analysis
The phenolic content of the extracts was identiﬁed using an
AGILENT 6560 UHPLC-IM-QTOF-MS/MS system. This instrument is the
ﬁrst commercially-available uniform ﬁeld ion mobility coupled with
Agilent 1290 UHPLC which can combine both LC, IM and MS selectivity
and separation power. It can perform both quantitative and qualitative
analysis with high-speed analysis and sensitivity. It is a hybrid quad-
rupole system to the mass analyzer of Ion Mobility Time-of-Flight for
high-resolution accurate mass and accurate collision cross section (CCS)
measurement with the added dimension of separation for the most
complex samples. It uses a diode array (DA) detector in the wavelength
range of 190–640 nm for the real-time preliminary analysis of separated
sample mixtures during connection to a mass analyzer. For the analysis,
the extract (5 mg) was solubilized in methanol (1 mL). The separation
of the constituents was achieved using a mobile phase made up of 0.1%
formic acid in water and acetonitrile. The sample was injected into the
machine at a pre-set volume of 5 µL, maintaining a ﬂow rate of 0.2mL/
min. The identiﬁcation of the compounds was achieved by comparing
the determined molecular weights to the theoretical molecular weights
(MS/MS) from a standard database (NIST Mass Spectrometry Data
Center) and calculating the mass error (ppm). This mass comparison
and mass error calculation were automatically performed by the soft-
ware inbuilt in the machine (Hazrulrizawati et al., 2018).
2.9. Data analyses
The diﬀerences in the activity of diﬀerent fractions of the extracts
were evaluated using non-paired Student t-test at a signiﬁcance level of
p < 0.05, while the correlation of the antioxidant activity of the ex-
tracts with the TPC was determined using Cronbach alpha at the same
level of signiﬁcance in the Microsoft Excel® (Microsoft, Redmond, WA,
USA). The graphs were prepared with Origin 7.0 (Origin Labs,
Massachusetts, USA).
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3. Results and discussion
3.1. Total phenolics and ﬂavonoids contents (TPC and TFC)
The TPC and TFC of the acetone and ethyl acetate extracts of Enoki
caps are shown in Table 1. From the results, acetone extract contained
more TPC and TFC compared to the ethyl acetate fractions (p < 0.05).
This observation could be attributed to several factors, such as the
degree of polarity of the extraction solvent (acetone is more polar than
ethyl acetate), the presence of side chains, glycosidic bond formation,
or degree of aromatic rings conjugation. These factors interfere with the
solubility of several phenolic compounds (Hazrulrizawati et al., 2016).
Notably, the solubility of phenolic compounds in diﬀerent solvents
depends on two factors, ﬁrst is the number of OH− groups contained in
the compound, and second is the degree of polarity of the solvent.
Solubility largely increases with both an increasing number of OH−
groups and the solvent polarity (Liu et al., 2017). Visht and Chaturvedi
(2012) reported the existence of a dipole interactive force in polar
solvents and suggested that this force can increase the solubility of
molecules. Diﬀerent species of mushrooms contain diﬀerent phyto-
chemicals, but the biological activity of these mushroom extracts lar-
gely depend on the type of phytochemical they contain (such as simple
phenolics, ﬂavonoids, phenolic acids, or hydroxycinnamic acid deri-
vatives) (Liu et al., 2017). The observed solvent polarity-dependent
diﬀerences in the TPC and TFC of the studied fractions have also been
previously reported (Addai et al., 2013; Dar et al., 2016).
3.2. Antioxidant activity
The largely reported antioxidant activity of mushroom extracts has
often been attributed to the hydrogen-donating and singlet oxygen-
quenching attributes of their phenolic phytochemical content (Khan
et al., 2016). In this study, the extracts were tested for antioxidant
activities using 3 chemical guided assays (DPPH radical scavenging,
H2O2 radical scavenging, and FRAP (Alam et al., 2013). In determining
the antioxidant activity of an extract using any free radical-based
method (such as DPPH and H2O2), the presence of proton donors is
manifested in color formation indicating the acceptance of hydrogen
radicals and diamagnetic molecules formation (Baratzadeh et al.,
2013). The reducing power-based assays (such as FRAP) assess the
ability of the extract to reduce the oxidation state of a metal (such as
the reduction of Fe3+ to Fe2+).
The antioxidant activities of the extracts were compared to that of
ascorbic acid (Figs. 1 and 2, and Table 2). Acetone extract was found to
show more antioxidant activity against DPPH (IC50= 0.84mg/mL) and
H2O2 (IC50= 0.89mg/mL) compared to ethyl acetate fraction (DPPH
IC50= 0.99mg/mL and H2O2 IC50= 1.35mg/mL). A lower activity
was noted with the ethyl acetate extract likely due to the type of phy-
tochemicals extracted with ethyl acetate (highly non-polar) compared
to those extracted with acetone. This could be due to the presence of
certain groups (such as glycosides) extracted by acetone which can
participate in antioxidant activities via proton transfer to radicals,
leading to the formation of phenoxide radicals and a consequent sta-
bilization of unstable radicals (Hazrulrizawati et al., 2016; Siddhuraju
and Becker, 2003; Ukaegbu and Shah, 2017). These results agreed with
previous reports where higher extracts’ antioxidant activities were re-
ported against DPPH (Maskam et al., 2014) and H2O2 (Sroka and
Cisowski, 2003) using solvents of varying polarities.
The observed FRAP of the extracts is presented in Table 2. The FRAP
showed a similar trend of antioxidant activity to those against DPPH
and H2O2. The table showed that a better concentration-dependent
FRAP of the acetone extract compared to the ethyl acetate extract. The
reason for the notable diﬀerences in the FRAP of the diﬀerent fractions
is not far from those earlier discussed (solvent polarity and phyto-
chemical content). The extracts showed a signiﬁcantly lower FRAP
(p < 0.05) compared to ascorbic (Table 2). FRAP has been re-
commended by Hodzic et al. (2009) as a simple way of evaluating the
antioxidant activity of an extract, while Schafer and Buettner (2001)
suggested FRAP as a reliable way of assessing the antioxidant activity of
extracts. The FRAP of mushroom extracts has previously been corre-
lated to the ability of their inherent phytochemicals to donate hydrogen
ions (Moure et al., 2001) even though there are other factors (such as
solvent type) which can aﬀect the biological activity of extracts. From
the correlation studies, there was a positive relationship between the
extracts’ TPC and their antioxidant activities. The observed Pearson
coeﬃcients r of the relation between the TPC of acetone extract and its
antioxidant activities was r=0.974, while that of the ethyl acetate
Table 1
Total phenolic and total ﬂavonoid contents of acetone and ethyl acetate extracts
of Enoki caps.
Acetone fraction Ethyl acetate fraction
TPC (µg GAE/mg)
Enoki caps 62.46 ± 0.14a 48.41 ± 0.06a
TFC (µg QE/mg)
Enoki caps 56.52 ± 0.02b 41.22 ± 0.20b
Note: TPC=Total phenolic content. TFC=Total ﬂavonoid content.
GAE= gallic acid equivalent, QE=quercetin equivalent. Diﬀerent superscripts
within rows represent statistically signiﬁcant diﬀerence at p < 0.05; n= 3.
Fig. 1. DPPH radical scavenging activity of acetone and ethyl acetate fractions
of Enoki.
Fig. 2. H2O2 radical scavenging activity of acetone and ethyl acetate fractions
of Enoki caps.
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fraction was r=0.743. This is in agreement with the report of Bazzaz
et al. (2011) who reported a positive correlation between extracts’ TPC
and their antioxidant activities.
3.3. Cytotoxicity assay
Having shown a better antioxidant activity, the cytotoxicity of the
acetone extract was studied on three cell lines using an in vitro MTT
assay method. The extract concentration required to achieve a 50% cell
death (IC50 value) was determined and presented in Table 3. From the
table, the extract was found to be more antiproliferative against MCF-7
cell line (IC50 value ranged from 17.7 to 38.36 µg/mL) compared to
MDA-MB-231 cell line (IC50 value ranged from 114.5 µg/mL–184.2 µg/
mL) after 72 h. The Vero cells (MCF-10a) were highly insensitive to the
extracts even at higher concentrations, showing the lower toxicity of
the extracts to normal body cells compared to cancerous cells. The Vero
cells were about 2.19 times less sensitive to the extract compared to
MDA-MB-231 cells, and about 14.12 times less sensitive to the extract
compared to MCF-7 cells. This less sensitivity of the Vero cells to the
extract can be attributed to the absence of speciﬁc proteins expressed
by the cancerous cells which facilitate the binding of the active phy-
tochemicals in the extracts on the cells for the induction of apoptosis
(Hazrulrizawati et al., 2016). Doxorubicin, a standard chemother-
apeutic agent used as a positive control had more anticancer activity
Table 2
FRAP of acetone and ethyl acetate extracts of Enoki caps (Absorbance readings @ 700 nm).
Conc. (mg/mL) 0.2 0.4 0.6 0.8 1.0
Acetone fraction
Enoki caps 0.050 ± 0.001a 0.098 ± 0.003a 0.192 ± 0.002a 0.275 ± 0.001a 0.339 ± 0.001a
Ethyl acetate fraction
Enoki caps 0.029 ± 0.002b 0.081 ± 0.001b 0.174 ± 0.001b 0.231 ± 0.001b 0.291 ± 0.001b
Ascorbic acid 0.202 ± 0.002 0.796 ± 0.005 1.262 ± 0.001 1.824 ± 0.002 2.130 ± 0.002
Note: Diﬀerent superscripts within the same column represent statistically signiﬁcant diﬀerence compared to ascorbic acid at p < 0.05; n= 3.
Table 3
Anticancer activities of acetone extract of Enoki caps on MDA-MB-231, MCF-7,
and MCF-10a.
After 24 h After 48 h After 72 h
MDA-MB-231 184.20 133.62 114.50
MCF-7 38.36 26.34 17.70
MCF-10a > 250 >250 >250
*Doxorubicin
MDA-MB-231 9.44 7.38 7.33
MCF-7 4.34 3.72 3.25
MCF-10a 1.46 1.03 0.94
Note: Values are presented as the concentration of extracts (µg/mL) needed to
inhibit the cell line growth by 50% (IC50). MCF-10a=Vero or normal breast
cells. All experiments were performed in triplicate. * implies standard che-
motherapeutic agent.
Fig. 3. Morphology of cell lines: (a) and (b)=MCF-7 after 48 and 72 h of treatment with the mushroom extract (×40 magniﬁcation). (c) and (d)=MDA-MB-231
after 48 and 72 h of treatment with the extract (×40 magniﬁcation). (e) and (f) MCF-10a after 48 and 72 h of treatment with the extract (×40 magniﬁcation). (g),
(h), and (i)=Non-treated MCF-7, MDA-MB-231, and MCF-10a (×40 magniﬁcation). Black headed arrows pointing at the apoptotic (dead) cancer cells after
treatment with the extract.
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Table 4
List of identiﬁed compounds in the acetone fraction of Enoki caps using LC-MS-QTof analysis.
S/N Component name Formula Identiﬁcation
status
Observed
neutral
mass (Da)
Observed m/z Mass
error
(mDa)
Mass
error
(ppm)
Observed
RT (min)
Response Adducts Observed
CCS (Å2)
Total
Fragments
Found
1 Norbergenin C13H14O9 Identiﬁed 314.0623 359.0605 −1.5 −4.0 0.35 167 +HCOO 169.64 2
2 p-Tolualdehyde C7H6O2 Identiﬁed 122.0371 167.0354 0.4 2.2 0.44 214 +HCOO 132.27 0
3 Campneoside Ⅰ C30H38O16 Identiﬁed 654.2173 699.2155 1.3 1.8 0.45 137 +HCOO 243.06 30
4 Forsythoside D C20H30O13 Identiﬁed 478.1697 523.1679 1.0 2.0 0.45 649 +HCOO 200.75 26
5 Polygoacetophenoside C14H18O10 Identiﬁed 346.0882 345.0810 −1.8 −5.1 0.45 420 −H 168.51 25
6 Pyrogallic acid C6H6O3 Identiﬁed 126.0320 171.0302 0.3 1.9 0.46 290 +HCOO 155.45 0
7 Moracin G C19H16O4 Identiﬁed 308.1030 353.1012 −1.8 −5.2 0.46 280 +HCOO 173.61 8
8 3,5-O-Dicaﬀeoylquinic
acid
C25H24O12 Identiﬁed 516.1268 515.1196 0.1 0.1 0.46 1015 −H 201.59 32
9 3′-O-Methylbrazilin C17H16O5 Identiﬁed 300.1009 299.0937 1.2 3.9 0.46 609 −H 159.06 10
10 Renifolin C18H24O7 Identiﬁed 352.1534 397.1516 1.2 3.1 0.46 981 +HCOO 180.95 43
11 Renifolin C18H24O7 Identiﬁed 352.1538 397.1520 1.6 4.1 0.46 186 +HCOO 202.85 9
12 3,4-
Dihydroxyphenothyl-3-
O-β-D-glucopyranoside
C12H16O8 Identiﬁed 288.0859 333.0841 1.4 4.2 0.46 398 HCOO, −H 168.72 23
13 Norbergenin C13H14O9 Identiﬁed 314.0635 313.0562 −0.3 −0.8 0.46 474 −H, +HCOO 181.92 52
14 Polygoacetophenoside C14H18O10 Identiﬁed 346.0900 391.0882 0.0 0.1 0.46 1055 +HCOO, −H 175.04 63
15 2′-Hydroxy-3′,4′-
dimethoxy-isoﬂavan-7-
O-β-D-glucoside
C23H28O10 Identiﬁed 464.1676 463.1603 −0.7 −1.4 0.46 156 −H 207.86 25
16 Ehretioside B C14H17NO7 Identiﬁed 311.1013 356.0995 0.8 2.2 0.46 1038 +HCOO 173.62 40
17 Isotachioside C13H18O8 Identiﬁed 302.0994 347.0976 −0.8 −2.3 0.47 175 +HCOO 168.08 20
18 3,4-
Dihydroxybenzamide
C7H7NO3 Identiﬁed 153.0428 198.0410 0.2 0.9 0.47 615 +HCOO 153.04 0
19 1,5-Bis(4-hydroxy-3-
methoxyphenyl)-1,4-
pentadien-3-one
C19H18O5 Identiﬁed 326.1141 325.1068 −1.4 −4.2 0.47 2689 −H 167.23 6
20 Vanillin C8H8O3 Identiﬁed 152.0471 197.0453 −0.2 −1.1 0.47 147 +HCOO 164.25 0
21 Norbergenin C13H14O9 Identiﬁed 314.0641 359.0623 0.3 1.0 0.47 1298 +HCOO, −H 171.40 39
22 1-Galloyl-β-D-glucose C13H16O10 Identiﬁed 332.0741 377.0723 −0.2 −0.6 0.47 1482 +HCOO 172.30 44
23 2,4,5-Trihydeoxy
benzaldehyd
C7H6O4 Identiﬁed 154.0262 199.0244 −0.4 −2.2 0.47 234 +HCOO 129.29 0
24 Polygoacetophenoside C14H18O10 Identiﬁed 346.0901 345.0828 0.1 0.2 0.47 178 −H 201.82 14
25 Syringaldehyde C9H10O4 Identiﬁed 182.0574 227.0557 −0.5 −2.0 0.47 120 +HCOO 177.63 8
26 2,4,5-Trihydeoxy
benzaldehyd
C7H6O4 Identiﬁed 154.0263 199.0245 −0.3 −1.6 0.47 524 +HCOO 155.56 0
27 Catechol C6H6O2 Identiﬁed 110.0368 155.0350 0.0 0.2 0.47 117 +HCOO 163.78 0
28 Syringaldehyde C9H10O4 Identiﬁed 182.0567 227.0549 −1.2 −5.5 0.47 217 +HCOO 186.23 7
29 2′-Hydroxy-3′,4′-
dimethoxy-isoﬂavan-7-
O-β-D-glucoside
C23H28O10 Identiﬁed 464.1665 463.1592 −1.7 −3.7 0.49 193 −H 192.54 27
30 p-Hydroxyacetanilide C8H9NO2 Identiﬁed 151.0625 196.0607 −0.8 −4.3 0.50 159 +HCOO 139.51 0
31 3,4-Dihydroxyphene
thylamine
C8H11NO2 Identiﬁed 153.0790 198.0772 0.0 0.2 0.72 293 +HCOO 138.76 0
32 Osmanthuside H C19H28O11 Identiﬁed 432.1628 477.1610 −0.4 −0.8 3.69 2675 +HCOO 199.73 0
33 Forsythoside D C20H30O13 Identiﬁed 478.1690 477.1617 0.4 0.8 4.20 4402 −H 199.74 1
34 Forsythoside D C20H30O13 Identiﬁed 478.1678 523.1660 −0.8 −1.6 5.74 2609 +HCOO 205.36 3
35 Forsythoside D C20H30O13 Identiﬁed 478.1672 523.1654 −1.5 −2.8 6.57 1652 +HCOO 206.35 4
36 Xanthoxylin C10H12O4 Identiﬁed 196.0749 241.0731 1.3 5.5 9.30 331 +HCOO 220.44 0
37 Renifolin C18H24O7 Identiﬁed 352.1519 351.1446 −0.3 −0.8 10.53 665 −H 179.19 0
38 6-Gingerol C17H26O4 Identiﬁed 294.1824 339.1806 −0.8 −2.2 11.57 1953 +HCOO 178.85 0
39 Brazilein C16H12O5 Identiﬁed 284.0688 329.0670 0.3 0.9 14.20 3897 +HCOO 175.23 0
Fig 4. Base Peak Intensity plot of LC-MS-QTOF-identiﬁed phytochemicals in acetone fraction of Enoki caps showing the retention times of the phytochemicals.
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against both cells (IC50 value ranged from 12.3 to 17.4 µg/mL against
MDA-MB-231, and 5.4–7.7 µg/mL against MCF-7) compared to MCF-
10a. This higher cytotoxicity of doxorubicin on the Vero cells can be
attributed to the non-selective side eﬀects of the chemotherapy agent.
Studies have previously reported several mushrooms as a source of
medicinal agents (Liu et al., 2017; Marijana et al., 2016). Various
mushrooms have historically been used to treat various diseases, in-
cluding cancer owing to their abundant steroids, polysaccharides,
proteoglycans and other bioactive content (Ding et al., 2012). Antic-
ancer agents are known to act as reactive oxygen species inducers,
angiogenesis inhibitors, mitotic kinase inhibitors, topoisomerase in-
hibitors, as well as inducers of apoptosis (Patel and Goyal, 2012). Re-
ports on the anticancer activity of edible mushrooms exist in the lit-
erature. Kim et al. (2010) reported the in vivo cytotoxicity of L.
deliciosus-derived hetero-polysaccharides. Similarly, Xu et al. (2012)
reported the capability of M. procera extract to inhibit the metastasis of
26- M3.1 cells.
3.3.1. Cell morphology
The morphology of the cell lines after 48 and 72 h of treatment with
the extract are shown in Fig. 3. The ﬁgures showed marked alterations
and deformations on the surface of the cells which could be attributed
to the extract-induced stress. A comparison of the treated and non-
treated cells showed marked morphological diﬀerences. The non-
treated cells were observed to have a better conﬂuency compared to the
distorted proliferation observed in the treated cells. Dead or apoptotic
cells were also observed in the cells treated with the extracts (black
headed arrows in the ﬁgures), showing the ability of the extract to in-
duce cell death.
3.4. LC-MS-QT of analysis
Being that phytochemicals are responsible for the observed antic-
ancer activity of the extract, a mass spectrometry analysis of the
acetone fraction of Enoki caps was carried out to identify its phyto-
chemical content. A complete list of the phytochemicals identiﬁed in
the extract is shown in Table 4, while the base peak intensity (BPI)
chromatograph (with retention times) and the structure of some of the
identiﬁed compounds are presented in Figs. 4 and 5, respectively. Some
of the identiﬁed compounds in the extract are xanthoxylin, 6-gingerol,
cyclocurcumin, dendrocandin 1, osmanthuside H, and forsythoside D. A
previous study has reported the ability of xanthoxylin in combination
with a novel ruthenium complex to mediate ERK1/2 apoptosis and
induce S-phase arrest in HepG2 cells via a p53-independent pathway
(de Carvalho et al., 2018). The concentration-dependent cytotoxicity of
6-gingerol against HCT15, L929, and Raw 264.7 has been reported as
well (Kumara et al., 2017). The antioxidant, anticancer, anti-in-
ﬂammatory, antimicrobial, cardioprotective, neuroprotective, and
radioprotective eﬀects of cyclocurcumin have been reported (Ataie
et al., 2010). These compounds were identiﬁed by comparing their
respective molecular weights to the theoretical molecular weights (MS/
MS) from a standard database (NIST Mass Spectrometry Data Center)
and calculating the mass error (ppm).
4. Conclusion
In this study, both acetone and ethyl acetate extracts of Enoki caps
were biologically characterized for antioxidant activities, but only
acetone extract was evaluated for in vitro anticancer activity against
MCF-7 and MDA-MB-231 (breast cancer cell lines) and MCF-10a (Vero
cells) due to its higher antioxidant activity compared to ethyl acetate
extract (p < 0.05). Furthermore, the anticancer activity evaluation
showed a selective activity of the acetone extract against the studied
cancer cells compared to the Vero cells. The proliferation of MCF-7 cell
line was highly inhibited compared to that of MDA-MB-231, while the
Vero cells almost showed no sensitivity to the extract. Therefore, it is
concluded that Enoki caps contain phytochemicals which can help
prevent the building up of free radicals in the body, and also curbed the
development of certain types of cancer.
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